More interesting is the sell from Bandera about the same buy from our latest hedge fund Roubaix Capital
Maybe Madeline Elaine Hedges (Chief Compliance Officer) with Bandera now for a couple months may know ( ex Dinsmore & Shohl LLP who has exosome patent clients etc )
Exosomes are alive and well in demand if one has the patents
Bandera to Roubaix and now forced to sell for some reason....very interesting
Almost as odd as it was to see Joel McComb just up and leave
Looks like some are forced to sell and some are forced to resign
Who is next?
Who will be the big name added to the BOD?
I wonder if Joel McComb is doing well lately with Point Break Capital hedge fund
The next BOD entrance should happen before the next cc and before revisions made to increase guidance revenue and result in decent stock options awards
Market Data 
Markets 
AI
